Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Return on Sales (2016 - 2025)

CorMedix has reported Return on Sales over the past 12 years, most recently at 0.0% for Q4 2025.

  • Quarterly results put Return on Sales at 0.0% for Q4 2025, down 1.0% from a year ago — trailing twelve months through Dec 2025 was 0.01% (changed 0.0% YoY), and the annual figure for FY2025 was 0.01%, changed 0.0%.
  • Return on Sales reached 0.0% in Q4 2025 per CRMD's latest filing, down from 0.01% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.01% in Q4 2024 and bottomed at 10.05% in Q3 2022.
  • Median Return on Sales over the past 4 years was 0.82% (2021), compared with a mean of 2.41%.
  • Peak annual rise in Return on Sales hit 208bps in 2022, while the deepest fall reached -838bps in 2022.
  • Over 4 years, Return on Sales stood at 1.71% in 2021, then plummeted by -61bps to 2.76% in 2022, then surged by 100bps to 0.01% in 2024, then crashed by -90bps to 0.0% in 2025.
  • Business Quant data shows Return on Sales for CRMD at 0.0% in Q4 2025, 0.01% in Q3 2025, and 0.0% in Q2 2025.